Gemcitabine-based induction chemotherapy and concurrent with radiation in advanced head and neck cancer

Medical Oncology

Volumn 29, Issue 5, 2012, Pages 3367-3373

  El Deen, Doaa Ali Sharaf ^a   Toson, Eman Abd Elkareem ^a   El Morsy, Shawky Mahmoud ^a  

^a MANSOURA UNIVERSITY   (Egypt)

Author keywords

Concurrent chemo radiotherapy; Gemcitabine based induction; Head and neck cancer

Indexed keywords

CISPLATIN; GEMCITABINE; ANTINEOPLASTIC AGENT; DEOXYCYTIDINE; DRUG DERIVATIVE;

ADULT; ADVANCED CANCER; AGED; ANEMIA; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER LOCALIZATION; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURVIVAL; CHEMORADIOTHERAPY; CLINICAL ARTICLE; DERMATITIS; DRUG EFFICACY; DYSGEUSIA; DYSPHAGIA; FEMALE; HEAD AND NECK SQUAMOUS CELL CARCINOMA; HUMAN; INDUCTION CHEMOTHERAPY; MALE; MULTIPLE CYCLE TREATMENT; NAUSEA; NEUTROPENIA; OVERALL SURVIVAL; PRIORITY JOURNAL; PROGRESSION FREE SURVIVAL; RECURRENCE FREE SURVIVAL; SIDE EFFECT; STOMATITIS; THROMBOCYTOPENIA; TREATMENT RESPONSE; VOMITING; WEIGHT REDUCTION; XEROSTOMIA; CANCER GRADING; CLINICAL TRIAL; DISEASE FREE SURVIVAL; HEAD AND NECK TUMOR; METHODOLOGY; MIDDLE AGED; MORTALITY; PATHOLOGY; SQUAMOUS CELL CARCINOMA;

ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA, SQUAMOUS CELL; CHEMORADIOTHERAPY; CISPLATIN; DEOXYCYTIDINE; DISEASE-FREE SURVIVAL; FEMALE; HEAD AND NECK NEOPLASMS; HUMANS; INDUCTION CHEMOTHERAPY; MALE; MIDDLE AGED; NEOPLASM GRADING; NEOPLASM STAGING;

EID: 84880309760     PISSN: 13570560     EISSN: 1559131X     Source Type: Journal    
DOI: 10.1007/s12032-012-0269-x     Document Type: Article

References (37)

1. Tobias JS. Cancer of the head and neck. BMJ. 1994;308:961-6.
2. Mohanti BK, Bahadur S, Lal P, et al. Cancers of the head and neck. In: Rath GK, Mohanti BK, editors. Text book of radiation oncology, principles and practice. New Delhi: B.I. Churchill Livingstone; 2000. p. 131-99.
3. Stupp R, Weichselbaum RR, Vokes EE. Combined modality therapy of head and neck cancer. Semin Oncol. 1994;21:349-58.
4. Gillison ML, Forastiere AA. Chemotherapy of head and neck cancers. In: Haskell CM, Berek JS, editors. Cancer treatment. 5th ed. USA: W.B. Saunders Company; 2001. p. 1030-42.
5. Adelstein DJ, Li Y, Adams GL, et al. An intergroup phase III comparison of standard radiation therapy and two schedules of concurrent chemoradiotherapy in patients with unresectable squamous cell head and neck cancer. J Clin Oncol. 2003;21:92-8.
6. Zorat PL, Paccagnella A, Cavaniglia G, et al. Randomized phase III trial of neoadjuvant chemotherapy in head and neck cancer: 10-year follow-up. J Natl Cancer Inst. 2004;96:1714-7.
7. Pignon JP, Bourhis J, Domenge C, et al. Chemotherapy added to locoregional treatment for head and neck squamous cell carcinoma: three meta-analyses of updated individual data. Lancet. 2000;355:949-55.
8. Vokes EE, Haraf DJ, Kies MS. The use of concurrent chemotherapy and radiotherapy for locoregionally advanced head and neck cancer. Semin Oncol. 2000;27(4) Suppl 8:34-8.
9. Forastiere AA, Goepfert H, Maor M, et al. Concurrent chemotherapy and radiotherapy for organ preservation in advanced laryngeal cancer. N Engl J Med. 2003;349:2091-8.
10. Bernier J, Cooper JS, Pajak TF, et al. Defining risk levels in locally advanced head and neck cancers: a comparative analysis of concurrent postoperative radiation plus chemotherapy trials of the EORTC (no. 22931) and RTOG (no. 9501). Head Neck. 2005;27:843-50.
11. Specenier PM, Vermorken JB. Neoadjuvant chemotherapy in head and neck cancer: should it be revised? Cancer Lett. 2007;256:166-77.
12. Posner M, Vermorken JB. Induction therapy in the modern era of combined-modality therapy for locally advanced head and neck cancer. Semin Oncol. 2008;35:221-8.
13. Catimel G, Vermorken JB, Clavel M, et al. A phase II study of Gemcitabine (LY 188011) in patients with advanced squamous cell carcinoma of the head and neck. EORTC Early Clinical Trials Group. Ann Oncol. 1994;5:543-7.
14. Lawrence TS, Eisbruch A, Schewach DS. Gemcitabine-mediated radiosensitization. Semin Oncol. 1997;24(Suppl 7):24.
15. Hitt R, Castellano D, Hidalgo M, et al. Phase II trial of cisplatin and gemcitabine in advanced squamous-cell carcinoma of the head and neck. Ann Oncol. 1998;9:1347-9.
16. Eisbruch A, Shewach DS, Bradford CR, et al. Radiation concurrent with gemcitabine for locally advanced head and neck cancer: a phase I trial and intracellular drug incorporation study. J Clin Oncol. 2001;19:792-9.
17. Pauwels B, Korst AE, Lardon F, et al. Combined modality of gemcitabine and radiation. Oncologist. 2005;10:34-51.
18. Plunkett W, Huang P, Xu Y-Z, et al. Gemcitabine: metabolism, mechanisms of actions, and self-potentiation. Semin Oncol. 1995;22(Suppl 11):3-10.
19. Guchelaar HJ, Richel DJ, van Knapen A. Clinical, toxicological and pharmacological aspects of gemcitabine. Cancer Treat Rev. 1996;22:13-31.
20. Specenier PM, Weyler J, Van Laer C, et al. A non-randomized comparison of gemcitabine-based chemotherapy with or without induction chemotherapy for locally advanced squamous cell carcinoma of the head and neck. BMC Cancer. 2009;9:273.
21. Domenge C, Hill C, Lefebvre JL. Randomized trial of neoadjuvant chemotherapy in oropharyngeal carcinoma. French Groupe d'Etude des Tumeurs de la Tete et du Cou (GETTEC). Br J Cancer. 2000;83:1594-8.
22. Paccagnella A, Orlando A, Marchiori C. Phase III trial of initial chemotherapy in stage III or IV head and neck cancers: a study by the Gruppo di Studio sui Tumori della Testa e del Collo. J Natl Cancer Inst. 1994;86:265-72.
23. Prestwich RJ, Kancherla K, Oksuz D, et al. A single centre experience with sequential and concomitant chemoradiotherapy in locally advanced stage IV tonsillar cancer. Radiat Oncol. 2010;5:121.
24. Psyrri A, Kwong M, DiStasio S, et al. Cisplatin, fluorouracil, and leucovorin induction chemotherapy followed by concurrent cisplatin chemoradiotherapy for organ preservation and cure in patients with advanced head and neck cancer: long-term follow-up. J Clin Oncol. 2004;22:3061-9.
25. Urba SG, Moon J, Giri PG, et al. Organ preservation for advanced resectable cancer of the base of tongue and hypopharynx: a Southwest Oncology Group Trial. J Clin Oncol. 2005;23:88-95.
26. Bhide SA, Ahmed M, Barbachano Y, Newbold K, et al. Sequential induction chemotherapy followed by radical chemo-radiation in the treatment of locoregionally advanced head-and-neck cancer. Br J Cancer. 2008;99(1):57-62.
27. Chauhan A, Singh H, Sharma T, et al. Gemcitabine concurrent with radiation therapy for locally advanced head and neck carcinomas. Afr Health Sci. 2008;8(3):149-55.
28. Specenier PM, Van den Weyngaert D, Van Laer C, et al. Phase II feasibility study of concurrent radiotherapy and gemcitabine in chemonaive patients with squamous cell carcinoma of the head and neck: long-term follow up data. Ann Oncol. 2007;18(11):1856-60.
29. Krstevska V, Stojkovski I, Lukarski D. Concurrent radiochemotherapy in advanced hypopharyngeal cancer. Radiat Oncol. 2010;5:39.
30. Benasso M, Corvo R, Ponzanelli A, et al. Alternating gemcitabine and cisplatin with gemcitabine and radiation in stage IV squamous cell carcinoma of the head and neck. Ann Oncol. 2004;15:646-52.
31. Hung SK, Chen HL, Hsieh CH, et al. Treatment of advanced hypopharyngeal cancer-comparison of two modalities. Tzu Chi Med J. 2006;18:15-21.
32. Lee NY, O'Meara W, Chan K, et al. Concurrent chemotherapy and intensity-modulated radiotherapy for locoregionally advanced laryngeal and hypopharyngeal cancer. Int J Radiat Oncol Biol. 2007;69:459-68.
33. Yoon MS, Chung WK, Ahn SJ. Concurrent chemoradiotherapy with cisplatin and fluorouracil for locally advanced hypopharyngeal carcinoma. Acta Oto-Laryngol. 2008;128:590-6.
34. Graf R, Hildebrandt B, Tilly W, et al. A non-randomised, single-centre comparison of induction chemotherapy followed by radiochemotherapy versus concomitant chemotherapy with hyperfractionated radiotherapy in inoperable head and neck carcinomas. BMC Cancer. 2006;6:30.
35. Chitapanarux I, Tharavichitkul E, Lorvidhaya V, et al. Induction chemotherapy with paclitaxel, ifosfamide, and cisplatin followed by concurrent chemoradiotherapy for unresectable locally advanced head and neck cancer. Biomed Imaging Interv J. 2010;6(3):e23.
36. Wildfang I, Raub M, Guner SA. Low dose gemcitabine with radiotherapy in advanced head and neck and thyroid cancer, a new radiosensitizing approach. J Can Res Clin Oncol. 2000;126(1):R40.
37. Hanna E, Alexiou M, Morgan J. Intensive chemoradiotherapy is a primary treatment for organ preservation in patients with advanced cancer of the head and neck. Arch Otolaryngol Head Neck Surg. 2004;130:861-7.